Related Experiment Video

Updated: Apr 21, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

20.8K

Engineering megakaryocytes with oncolytic viruses for in situ generation of therapeutic platelets

Yinxian Yang1,2, Zhen Gu1,3, Jicheng Yu1,3

  • 1State Key Laboratory of Advanced Drug Delivery and Release Systems, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.

Molecular Therapy. Oncology
|April 20, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation
06:57

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation

Published on: May 20, 2021

4.7K
Isolation of Mouse Megakaryocyte Progenitors
10:30

Isolation of Mouse Megakaryocyte Progenitors

Published on: May 20, 2021

7.8K

Related Experiment Videos

Last Updated: Apr 21, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

20.8K
Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation
06:57

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation

Published on: May 20, 2021

4.7K
Isolation of Mouse Megakaryocyte Progenitors
10:30

Isolation of Mouse Megakaryocyte Progenitors

Published on: May 20, 2021

7.8K

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

7.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
7.1K

Articles linked to this work by shared authors, journal, and citation graph.

Platelet-phage conjugates for targeted therapy of acute bacterial pneumonia.

Biomaterials·2026

Degradation of levofloxacin by a photodeposited Pt/TiO2 porous ceramic composite under UV irradiation and analysis of transformation pathways.

Food chemistry·2026

Artificial Intelligence for Drug Delivery.

ACS nano·2026

Harnessing a marine-derived Rhodococcus strain for cross-habitat bioaugmentation of malodorant skatole: Performance and ecological response.

Marine pollution bulletin·2026

Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JMKX003002 in Chinese healthy participants: a randomized, double-blind, placebo-controlled, single- and multiple-ascending dose, and food-effect phase I clinical trial.

Annals of medicine·2026

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases.

Science translational medicine·2026

A p53R273H-selective bispecific T cell engager: Computational design and functional validation.

Molecular therapy. Oncology·2026

Erratum: AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.

Molecular therapy. Oncology·2026

Erratum: Intramuscular plasmid DNA electroporation sequesters neoantigen-specific CD8+ T cells in treated muscle and limits tumor infiltration.

Molecular therapy. Oncology·2026

Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway.

Molecular therapy. Oncology·2026

Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety.

Molecular therapy. Oncology·2026

USP15 regulates mitotic fidelity, metastatic potential, and chemotherapeutic response in ovarian cancer cells.

Molecular therapy. Oncology·2026

Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 (SeaLAND) trial.

British journal of haematology·2026

Tat-dependent protein translocation and its evolution.

FEMS microbiology reviews·2026

Theranostics in the management of prostate cancer: from concept to clinical practice.

Expert review of clinical pharmacology·2026

miR-324-5p acts as an independent prognostic biomarker and inhibits pediatric medulloblastoma progression by targeting HOXA9.

Nucleosides, nucleotides & nucleic acids·2026

Th1-biased iNKT cell agonist-loaded liposomal peptide vaccines synergize with a PD-L1 inhibitor to boost immunotherapy against gastric cancer.

Chemical communications (Cambridge, England)·2026

Nanoparticle-Based Delivery Strategies for Targeted Protein Degradation.

Advanced healthcare materials·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us